ANAB vs RUN · rev $91.3M vs P/E 6.0, rev $2.04B
AnaptysBio Inc (ANAB) versus Sunrun Inc (RUN) — a side-by-side from cached financials, not a winner call.
AnaptysBio Inc (ANAB) is a biotechnology company listed on NASDAQ.
Sunrun Inc (RUN) is a solar company listed on NASDAQ.
Latest reported ANAB revenue for 2024-12-31 was $91.3M. Net income was -$145.2M. Revenue was up 432.0% from 2023-12-31 to 2024-12-31. ANAB currently screens at market cap $1.62B.
Latest reported RUN revenue for 2024-12-31 was $2.04B. Net income was -$4.36B. Revenue was down 9.8% from 2023-12-31 to 2024-12-31. RUN currently screens at market cap $3.05B and trailing P/E 6.0.
ANAB currently screens at market cap $1.62B. RUN currently screens at market cap $3.05B and trailing P/E 6.0.
Not investment advice. Open the ANAB and RUN stock pages for the full models.
Not investment advice.